Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Molecular Pathology Unit, Department of Biochemistry, Edouard Herriot University Hospital, Lyon, France.
We report the clinical and biochemical studies of a patient initially diagnosed with β-thalassemia intermedia (β-TI), which, with age, has progressed to a severe transfusion-dependent form. The patient is a compound heterozygote for the -30 (T>A) β(+)-thalassemia (β(+)-thal) mutation and the rare δ(0)β(+)-Senegalese deletion. Many complications are reported as well as the specific treatments initiated.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on